北京大学学报(医学版) ›› 2025, Vol. 57 ›› Issue (2): 245-252. doi: 10.19723/j.issn.1671-167X.2025.02.004
Wei FU, Jing NING, Weiwei FU, Jing ZHANG*(
), Shigang DING*(
)
摘要:
目的: 探索幽门螺杆菌(Helicobacter pylori,Hp)感染后胃黏膜上皮细胞中含MARVEL结构域的CKLF样因子6(CKLF-like MARVEL transmembrane domain-containing 6,CMTM6)、程序性死亡配体(programmed death-ligand 1,PD-L1)表达水平变化及CMTM6对PD-L1的调控作用,并通过微列阵分析探索CMTM6基因敲除前后Hp感染的胃黏膜上皮细胞mRNA表达差异变化情况。方法: 将Hp标准菌株ATCC 26695与人胃黏膜上皮细胞GES-1共培养6 h、24 h及48 h,通过实时荧光定量PCR及免疫印迹法检测CMTM6及PD-L1表达水平。利用CRISPR/Cas9技术构建CMTM6基因敲除质粒并敲除GES-1细胞的CMTM6基因。将Hp分别与CMTM6基因敲除和野生型GES-1细胞共培养48 h,检测PD-L1转录及蛋白质水平的变化,并利用蛋白酶体抑制剂MG-132处理CMTM6基因敲除GES-1细胞,检测PD-L1蛋白水平变化。利用Agilent Human ceRNA Microarray 2019对与Hp共培养48 h的CMTM6基因敲除和野生型GES-1细胞进行mRNA微列阵分析,得到差异表达基因并通过日本京都基因与基因组百科(Kyoto Encyclopedia of Genes and Genomes,KEGG)数据库分析差异表达基因富集的信号通路。结果: Hp感染后,GES-1细胞的CMTM6、PD-L1的mRNA及蛋白水平均明显上调,CMTM6 mRNA在感染后48 h上调最明显。CMTM6基因敲除后,Hp感染的GES-1细胞CD274基因转录水平无明显变化,但PD-L1蛋白水平明显下调,应用蛋白酶体抑制剂MG-132处理后PD-L1水平回升。CMTM6基因敲除后,67个基因表达差异达到2倍以上,其中TMEM68、FERMT3、GPR142、ATP6V1FNB、NOV、UBE2S等基因转录水平明显下调,PCDHGA6、CAMKMT、PDIA2、NTRK3、SPOCK1等基因转录水平明显上调。CMTM6基因敲除后,编码泛素结合酶E2S(ubiquitin-conjugating enzyme E2S,UBE2S)的基因表达明显下调,可能影响蛋白质泛素化降解。CMTM6基因敲除后,编码肾上腺素能受体α1B(adrenoceptor alpha 1B,ADRA1B)、乙酰胆碱毒蕈碱受体M1(cholinergic receptor muscarinic 1,CHRM1)及血小板活化因子受体(platelet activating factor receptor,PTAFR)的基因表达明显上调。结论: Hp感染上调胃黏膜细胞CMTM6水平,CMTM6发挥稳定PD-L1的作用;CMTM6基因敲除可能影响蛋白质泛素化降解、细胞表面受体表达。
中图分类号:
| 1 |
Oster P , Vaillant L , Riva E , et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J]. Gut, 2022, 71 (3): 457- 466.
doi: 10.1136/gutjnl-2020-323392 |
| 2 | Correa P . Human gastric carcinogenesis: A multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention[J]. Cancer Res, 1992, 52 (24): 6735- 6740. |
| 3 |
Asaka M , Sugiyama T , Nobuta A , et al. Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study[J]. Helicobacter, 2001, 6 (4): 294- 299.
doi: 10.1046/j.1523-5378.2001.00042.x |
| 4 | Zhao M , Liu Q , Liu W , et al. MicroRNA140 suppresses Helicobacter pyloripositive gastric cancer growth by enhancing the antitumor immune response[J]. Mol Med Rep, 2019, 20 (3): 2484- 2492. |
| 5 |
Xie G , Li W , Li R , et al. Helicobacter pylori promote B7-H1 expression by suppressing miR-152 and miR-200b in gastric cancer cells[J]. PLoS One, 2017, 12 (1): e0168822.
doi: 10.1371/journal.pone.0168822 |
| 6 |
Holokai L , Chakrabarti J , Broda T , et al. Increased programmed death-ligand 1 is an early epithelial cell response to Helicobacter pylori infection[J]. PLoS Pathog, 2019, 15 (1): e1007468.
doi: 10.1371/journal.ppat.1007468 |
| 7 |
Beswick EJ , Pinchuk IV , Das S , et al. Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells[J]. Infect Immun, 2007, 75 (9): 4334- 4341.
doi: 10.1128/IAI.00553-07 |
| 8 |
Wu YY , Lin CW , Cheng KS , et al. Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection[J]. Clin Exp Immunol, 2010, 161 (3): 551- 559.
doi: 10.1111/j.1365-2249.2010.04217.x |
| 9 |
Burr ML , Sparbier CE , Chan YC , et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity[J]. Nature, 2017, 549 (7670): 101- 105.
doi: 10.1038/nature23643 |
| 10 |
Mezzadra R , Sun C , Jae LT , et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators[J]. Nature, 2017, 549 (7670): 106- 110.
doi: 10.1038/nature23669 |
| 11 |
Guan X , Zhang C , Zhao J , et al. CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomas[J]. EBioMedicine, 2018, 35, 233- 243.
doi: 10.1016/j.ebiom.2018.08.012 |
| 12 |
Tian Y , Sun X , Cheng G , et al. The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer[J]. Ann Transl Med, 2021, 9 (2): 131.
doi: 10.21037/atm-20-7616 |
| 13 |
Ishihara S , Iwasaki T , Kohashi K , et al. The association between the expression of PD-L1 and CMTM6 in undifferentiated pleomorphic sarcoma[J]. J Cancer Res Clin Oncol, 2021, 147 (7): 2003- 2011.
doi: 10.1007/s00432-021-03616-4 |
| 14 | Li X , Chen L , Gu C , et al. CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients[J]. PeerJ, 2020 (8): e9536. |
| 15 |
Wang Z , Peng Z , Liu Q , et al. Co-expression with membrane CMTM6/4 on tumor epithelium enhances the prediction value of PD-L1 on anti-PD-1/L1 therapeutic efficacy in gastric adenocarcinoma[J]. Cancers (Basel), 2021, 13 (20): 5175.
doi: 10.3390/cancers13205175 |
| 16 |
Chen L , Yang QC , Li YC , et al. Targeting CMTM6 suppresses stem cell-like properties and enhances antitumor immunity in head and neck squamous cell carcinoma[J]. Cancer Immunol Res, 2020, 8 (2): 179- 191.
doi: 10.1158/2326-6066.CIR-19-0394 |
| 17 |
Huang X , Xiang L , Wang B , et al. CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells[J]. J Transl Med, 2021, 19 (1): 120.
doi: 10.1186/s12967-021-02787-5 |
| 18 |
Jin MH , Nam AR , Park JE , et al. Therapeutic co-targeting of WEE1 and ATM downregulates PD-L1 expression in pancreatic cancer[J]. Cancer Res Treat, 2020, 52 (1): 149- 166.
doi: 10.4143/crt.2019.183 |
| 19 | Tanaka E , Miyakawa Y , Kishikawa T , et al. Expression of circular RNA CDR1AS in colon cancer cells increases cell surface PDL1 protein levels[J]. Oncol Rep, 2019, 42 (4): 1459- 1466. |
| 20 |
Yamamoto Y , Kakizaki M , Shimizu T , et al. PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug entecavir[J]. Int Immunol, 2020, 32 (8): 519- 531.
doi: 10.1093/intimm/dxaa018 |
| 21 | Ho JY , Lu HY , Cheng HH , et al. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells[J]. Cell Oncol (Dordr), 2021, 44 (6): 1325- 1338. |
| [1] | 管仁珍, 丁士刚, 石岩岩, 薛艳. 含铋剂四联疗法根除幽门螺杆菌的疗效:4 261例患者的真实世界研究[J]. 北京大学学报(医学版), 2024, 56(5): 942-945. |
| [2] | 田雪丽,宋志强,索宝军,周丽雅,李彩玲,张雨欣. 比较Epsilometer试验法和琼脂稀释法检测幽门螺杆菌对甲硝唑的敏感性[J]. 北京大学学报(医学版), 2023, 55(5): 934-938. |
| [3] | 侯卫华,宋书杰,石中月,金木兰. 幽门螺杆菌阴性早期胃癌的临床病理特征[J]. 北京大学学报(医学版), 2023, 55(2): 292-298. |
| [4] | 王子靖,李在玲. 有幽门螺杆菌感染家族史儿童胃部菌群的特点[J]. 北京大学学报(医学版), 2021, 53(6): 1115-1121. |
| [5] | 杨光,程庆砾,李春霖,贾雅丽,岳文,裴雪涛,刘洋,赵佳慧,杜婧,敖强国. 高糖减弱肾组织干细胞条件培养液对缺氧损伤肾小管上皮细胞的修复作用[J]. 北京大学学报(医学版), 2017, 49(1): 125-130. |
| [6] | 余婧婷, 孟焕新, 刘凯宁. 改良人牙龈上皮细胞原代培养方法[J]. 北京大学学报(医学版), 2016, 48(4): 733-737. |
| [7] | 张文晓, 尚静, 郜鑫, 栾先国, 李苹, 王天晶, 胡贵平, 朱彤, 贾光. 1,4-萘醌老化黑碳对人支气管上皮细胞活性氧和DNA链断裂的影响[J]. 北京大学学报(医学版), 2015, 47(4): 690-696. |
| [8] | 任玉兰, 战园, 路璐, 李盛林, 傅歆, 俞光岩, 曹彤, 刘鹤. 人胚胎干细胞分化为角质形成细胞过程中标志物的表达特点[J]. 北京大学学报(医学版), 2015, 47(2): 305-311. |
| [9] | 钟金晟, 梅芳, 张宏权. 人牙龈结合上皮细胞和口腔龈上皮细胞生物学特性的比较[J]. 北京大学学报(医学版), 2015, 47(1): 32-36. |
| [10] | 石岩岩, 丁士刚, 张婷, 鲁凤民 , 张静, 王晔. 幽门螺杆菌硫氧还蛋白-1基因克隆及其重组蛋白表达与活性测定[J]. 北京大学学报(医学版), 2014, 46(2): 190-194. |
| [11] | 张治草,黄毅,王秀杰,王猛,马潞林. 膀胱尿路上皮癌患者血液中微小RNA的表达[J]. 北京大学学报(医学版), 2013, 45(4): 532-. |
| [12] | 温静,程庆砾,马强,齐云,赵佳慧,杜婧,王小丹,刘胜,李美花,张晓英. 肾组织干细胞对人肾小管上皮细胞损伤修复的作用[J]. 北京大学学报(医学版), 2013, 45(4): 619-. |
| [13] | 濮吉, 陈田, 陈章健, 王海芳, 聂海瑜, 贾光. 比较不同长度及表面修饰的多壁碳纳米管的细胞毒性和遗传毒性[J]. 北京大学学报(医学版), 2013, 45(03): 405-411. |
| [14] | 严颖, 程建平, 邸立军, 宋国红, 任军. 转移性乳腺癌上皮特异性细胞粘附分子(EpCAM) mRNA阳性循环肿瘤细胞检测及其临床价值[J]. 北京大学学报(医学版), 2012, 44(2): 275-280. |
| [15] | 张静, 丁士刚, 杨雪玲, 王晔, 张贺军. 胃黏膜病理学改变、体重指数与血清ghrelin和瘦素关系的研究[J]. 北京大学学报(医学版), 2010, 42(5): 543-546. |
|
||